Your browser doesn't support javascript.
loading
Programmable RNA-Guided RNA Effector Proteins Built from Human Parts.
Rauch, Simone; He, Emily; Srienc, Michael; Zhou, Huiqing; Zhang, Zijie; Dickinson, Bryan C.
Afiliação
  • Rauch S; Department of Chemistry, The University of Chicago, Chicago, Illinois, USA; Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, Illinois, USA.
  • He E; Department of Chemistry, The University of Chicago, Chicago, Illinois, USA.
  • Srienc M; Pritzker School of Medicine, The University of Chicago, Chicago, Illinois, USA.
  • Zhou H; Department of Chemistry, The University of Chicago, Chicago, Illinois, USA; Institute for Biophysical Dynamics, The University of Chicago, Chicago, Illinois, USA.
  • Zhang Z; Department of Chemistry, The University of Chicago, Chicago, Illinois, USA.
  • Dickinson BC; Department of Chemistry, The University of Chicago, Chicago, Illinois, USA. Electronic address: dickinson@uchicago.edu.
Cell ; 178(1): 122-134.e12, 2019 06 27.
Article em En | MEDLINE | ID: mdl-31230714
Epitranscriptomic regulation controls information flow through the central dogma and provides unique opportunities for manipulating cells at the RNA level. However, both fundamental studies and potential translational applications are impeded by a lack of methods to target specific RNAs with effector proteins. Here, we present CRISPR-Cas-inspired RNA targeting system (CIRTS), a protein engineering strategy for constructing programmable RNA control elements. We show that CIRTS is a simple and generalizable approach to deliver a range of effector proteins, including nucleases, degradation machinery, translational activators, and base editors to target transcripts. We further demonstrate that CIRTS is not only smaller than naturally occurring CRISPR-Cas programmable RNA binding systems but can also be built entirely from human protein parts. CIRTS provides a platform to probe fundamental RNA regulatory processes, and the human-derived nature of CIRTS provides a potential strategy to avoid immune issues when applied to epitranscriptome-modulating therapies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA / Engenharia de Proteínas / RNA Guia de Cinetoplastídeos / Nucleases dos Efetores Semelhantes a Ativadores de Transcrição / Edição de Genes Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA / Engenharia de Proteínas / RNA Guia de Cinetoplastídeos / Nucleases dos Efetores Semelhantes a Ativadores de Transcrição / Edição de Genes Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article